Differin Acne-Prone Skin Patches for Early-Stage Imperfections, Formulated with Salicylic Acid and Centella, Fast Triple Action Power Patch for Day & Night, Dermatologist Tested, 36 Count
$9.99
Price: $9.99
(as of Apr 11, 2024 11:49:30 UTC – Details)
Take on trouble spots with Differin Acne-Prone Skin Patches. Formulated with salicylic acid, these patches exfoliate to help shrink the appearance of imperfections. These invisible ultra-thin patches are makeup-friendly, waterproof, and sweatproof, so you can wear them day and night. The triple-action technology starts working fast to flatten, soothe, and protect the area. Dermatologist-tested, the patches are for all skin types, including acne-prone skin. Each box comes with 36 clear, easy-to-peel patches (18 small and 18 large) for any imperfection emergency. After cleaning and drying the area, place a patch on the imperfection. Leave it on for 4 to 12 hours, remove, and discard. Reapply a new patch as necessary.
Package Dimensions : 5.28 x 3.58 x 1.02 inches; 0.63 ounces
UPC : 302990851083
Manufacturer : Galderma Laboratories, Inc
ASIN : B0CJYJGQ5Z
TARGETS EMERGING IMPERFECTIONS: Targets emerging signs of an imperfection. Contains 36 patches in 2 different sizes (13.5mm or 11mm).
STARTS WORKING FAST: Triple-action patches flatten, soothe, and protect the area. Patch the imperfection to help prevent further irritation.
INVISIBLE ULTRA-THIN: Easy to peel, large and small patches for any emerging imperfections.
TRIPLE-ACTION TECHNOLOGY: Salicylic acid exfoliates to help shrink the appearance of trouble spots, while soothing centella asiatica and Canadian willowherb help to visibly reduce the look of redness.
FOR DAY AND NIGHT: Extra-thin patches are makeup-friendly, waterproof, and sweatproof, so you can wear them anytime
User Reviews
Be the first to review “Differin Acne-Prone Skin Patches for Early-Stage Imperfections, Formulated with Salicylic Acid and Centella, Fast Triple Action Power Patch for Day & Night, Dermatologist Tested, 36 Count”
$9.99
There are no reviews yet.